ID

30050

Descrizione

Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic Syndrome; ODM derived from: https://clinicaltrials.gov/show/NCT00542269

collegamento

https://clinicaltrials.gov/show/NCT00542269

Keywords

  1. 05/05/18 05/05/18 -
Titolare del copyright

See clinicaltrials.gov

Caricato su

5 maggio 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Hypertension With Metabolic Syndrome NCT00542269

Eligibility Hypertension With Metabolic Syndrome NCT00542269

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
outpatients 18-75 years of age.
Descrizione

Outpatients | Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0029921
UMLS CUI [2]
C0001779
male or female patients are eligible.
Descrizione

Gender

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0079399
patients with a diagnosis of hypertension:
Descrizione

Hypertensive disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0020538
newly diagnosed patients or patients who have not been treated for hypertension within the 4 weeks prior to visit 1 must have a mean sitting systolic blood pressure (mssbp) > 150 mmhg and < 180 mmhg at visit 1.
Descrizione

Patients Newly Diagnosed | Antihypertensive therapy Absent | Sitting systolic blood pressure mean

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1518321
UMLS CUI [2,1]
C0585941
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C1319893
UMLS CUI [3,2]
C0444504
patients treated with antihypertensive monotherapy must have a mssbp ≥ 140 mmhg and <180 mmhg at visit 1.
Descrizione

Antihypertensive therapy | Sitting systolic blood pressure mean

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0585941
UMLS CUI [2,1]
C1319893
UMLS CUI [2,2]
C0444504
patients taking amlodipine monotherapy mssbp > 140 mmhg and < 180 mmhg at visit 1.
Descrizione

Amlodipine | Sitting systolic blood pressure mean

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0051696
UMLS CUI [2,1]
C1319893
UMLS CUI [2,2]
C0444504
all patients must have a mssbp ≥ 140 mmhg and < 180 mmhg at visit 3, the end of the amlodipine run-in period.
Descrizione

Patients All | Sitting systolic blood pressure mean

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0444868
UMLS CUI [2,1]
C1319893
UMLS CUI [2,2]
C0444504
metabolic syndrome.
Descrizione

Metabolic Syndrome

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0524620
patients who are eligible and able to participate in the study, and who consent to do so after the purpose and nature of the investigation has been clearly explained to them (written inform consent form).
Descrizione

Study Subject Participation Status eligible | Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C1548635
UMLS CUI [2]
C0021430
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
severe hypertension (office cuff msdbp ≥ 115 mmhg and/or mssbp ≥ 180 mmhg).
Descrizione

Hypertension, severe | Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean

Tipo di dati

boolean

Alias
UMLS CUI [1]
C4013784
UMLS CUI [2,1]
C1319894
UMLS CUI [2,2]
C0444504
UMLS CUI [3,1]
C1319893
UMLS CUI [3,2]
C0444504
history or evidence of a secondary form of hypertension.
Descrizione

Secondary hypertension

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0155616
history of hypertensive encephalopathy or cerebrovascular accident, transient ischemic cerebral attack (tia), myocardial infarction, coronary bypass surgery, or any percutaneous coronary intervention (pci).
Descrizione

Hypertensive Encephalopathy | Cerebrovascular accident | Transient Ischemic Attack | Myocardial Infarction | Coronary Artery Bypass Surgery | Percutaneous Coronary Intervention

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0151620
UMLS CUI [2]
C0038454
UMLS CUI [3]
C0007787
UMLS CUI [4]
C0027051
UMLS CUI [5]
C0010055
UMLS CUI [6]
C1532338
serum sodium < 135 mmol/l at visit 1 if confirmed on repeat sample.
Descrizione

Serum sodium measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0523891
serum potassium < 3.5 mmol/l or ≥ 5.3 mmol/l at visit 1, if confirmed on repeat sample.
Descrizione

Serum potassium measurement

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0302353
type 1 diabetes mellitus.
Descrizione

Diabetes Mellitus, Insulin-Dependent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011854
type 2 diabetes if oral hypoglycaemic therapy changed (dose change or medication change) in previous 3 months.
Descrizione

Diabetes Mellitus, Non-Insulin-Dependent | ORAL HYPOGLYCEMIC TREATMENT Changed | Drug dosage altered | Change of medication

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2,1]
C0747045
UMLS CUI [2,2]
C0392747
UMLS CUI [3]
C0420247
UMLS CUI [4]
C0580105
pregnant or nursing (lactating) women.
Descrizione

Pregnancy | Breast Feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
other protocol-defined inclusion/exclusion criteria applied to the study.
Descrizione

Eligibility Criteria Study Protocol

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563

Similar models

Eligibility Hypertension With Metabolic Syndrome NCT00542269

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Outpatients | Age
Item
outpatients 18-75 years of age.
boolean
C0029921 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Gender
Item
male or female patients are eligible.
boolean
C0079399 (UMLS CUI [1])
Hypertensive disease
Item
patients with a diagnosis of hypertension:
boolean
C0020538 (UMLS CUI [1])
Patients Newly Diagnosed | Antihypertensive therapy Absent | Sitting systolic blood pressure mean
Item
newly diagnosed patients or patients who have not been treated for hypertension within the 4 weeks prior to visit 1 must have a mean sitting systolic blood pressure (mssbp) > 150 mmhg and < 180 mmhg at visit 1.
boolean
C0030705 (UMLS CUI [1,1])
C1518321 (UMLS CUI [1,2])
C0585941 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1319893 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
Antihypertensive therapy | Sitting systolic blood pressure mean
Item
patients treated with antihypertensive monotherapy must have a mssbp ≥ 140 mmhg and <180 mmhg at visit 1.
boolean
C0585941 (UMLS CUI [1])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
Amlodipine | Sitting systolic blood pressure mean
Item
patients taking amlodipine monotherapy mssbp > 140 mmhg and < 180 mmhg at visit 1.
boolean
C0051696 (UMLS CUI [1])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
Patients All | Sitting systolic blood pressure mean
Item
all patients must have a mssbp ≥ 140 mmhg and < 180 mmhg at visit 3, the end of the amlodipine run-in period.
boolean
C0030705 (UMLS CUI [1,1])
C0444868 (UMLS CUI [1,2])
C1319893 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
Metabolic Syndrome
Item
metabolic syndrome.
boolean
C0524620 (UMLS CUI [1])
Study Subject Participation Status eligible | Informed Consent
Item
patients who are eligible and able to participate in the study, and who consent to do so after the purpose and nature of the investigation has been clearly explained to them (written inform consent form).
boolean
C2348568 (UMLS CUI [1,1])
C1548635 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Hypertension, severe | Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean
Item
severe hypertension (office cuff msdbp ≥ 115 mmhg and/or mssbp ≥ 180 mmhg).
boolean
C4013784 (UMLS CUI [1])
C1319894 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C1319893 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
Secondary hypertension
Item
history or evidence of a secondary form of hypertension.
boolean
C0155616 (UMLS CUI [1])
Hypertensive Encephalopathy | Cerebrovascular accident | Transient Ischemic Attack | Myocardial Infarction | Coronary Artery Bypass Surgery | Percutaneous Coronary Intervention
Item
history of hypertensive encephalopathy or cerebrovascular accident, transient ischemic cerebral attack (tia), myocardial infarction, coronary bypass surgery, or any percutaneous coronary intervention (pci).
boolean
C0151620 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0007787 (UMLS CUI [3])
C0027051 (UMLS CUI [4])
C0010055 (UMLS CUI [5])
C1532338 (UMLS CUI [6])
Serum sodium measurement
Item
serum sodium < 135 mmol/l at visit 1 if confirmed on repeat sample.
boolean
C0523891 (UMLS CUI [1])
Serum potassium measurement
Item
serum potassium < 3.5 mmol/l or ≥ 5.3 mmol/l at visit 1, if confirmed on repeat sample.
boolean
C0302353 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes mellitus.
boolean
C0011854 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent | ORAL HYPOGLYCEMIC TREATMENT Changed | Drug dosage altered | Change of medication
Item
type 2 diabetes if oral hypoglycaemic therapy changed (dose change or medication change) in previous 3 months.
boolean
C0011860 (UMLS CUI [1])
C0747045 (UMLS CUI [2,1])
C0392747 (UMLS CUI [2,2])
C0420247 (UMLS CUI [3])
C0580105 (UMLS CUI [4])
Pregnancy | Breast Feeding
Item
pregnant or nursing (lactating) women.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria applied to the study.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial